Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Quadrisol   
Auth. number : EU/2/97/005
INN : Vedaprofen
ATC: Anatomical main group: QM - Musculo-skeletal system
Therapeutic subgroup: QM01 - Antiinflammatory and antirheumatic products
Pharmacological subgroup: QM01A - Antiinflammatory and antirheumatic products, non-steroids
Chemical subgroup: QM01AE - Propionic acid derivatives
Chemical substance: QM01AE90 - Vedaprofen
(See WHO ATCvet Index)
Indication: Reduction of inflammation and relief of pain associated with musculo-skeletal disorders and soft tissue lesions (traumatic injuries and surgical trauma). In cases of anticipated surgical trauma, Quadrisol can be given prophylactically at least 3 hours prior to elective surgery.
Marketing Authorisation Holder: Zoetis Belgium S.A.
Rue Laid Burniat 1, 1348 Louvain-La-Neuve, Belgique

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/12/1997 Centralised - Authorisation EMEA/V/C/32 (97)3892 of 04/12/1997
24/02/1999 Centralised - Authorisation EMEA/V/C/32/X (1999)360 of 15/02/1999
23/11/1999 Centralised - Authorisation EMEA/V/C/32/X (1999)3790 of 16/11/1999
02/02/2000 Centralised - Variation EMEA/V/C/32/I/1 (2000)122 of 28/01/2000
09/02/2000 Centralised - Variation EMEA/V/C/32/3/I/1 (2000)153 of 31/01/2000
14/06/2000 Centralised - Variation EMEA/V/C/32/3/I/2, 3 (2000)1459 of 09/06/2000
20/11/2000 Centralised - Variation EMEA/V/C/32/N/4 (2000)3236 of 16/11/2000
03/05/2001 Centralised - Variation EMEA/V/C/32/I/7
07/12/2001 Centralised - Variation EMEA/V/C/32/II/12 (2001)4027 of 05/12/2001
15/07/2002 Centralised - Variation EMEA/V/C/32/X/6 (2002)2709 of 10/07/2002
02/10/2002 Centralised - Variation EMEA/V/C/32/I/15 (2002)3661 of 30/09/2002
17/01/2003 Centralised - Renewal EMEA/V/C/32/R/14 (2003)320 of 15/01/2003
01/09/2003 Centralised - Variation EMEA/V/C/32/I/16 (2003)3175 of 28/08/2003
12/12/2003 Centralised - Variation EMEA/V/C/32/IB/17
12/03/2004 Centralised - Variation EMEA/V/C/32/IB/18
17/03/2004 Centralised - Variation EMEA/V/C/32/N/19 (2004)886 of 15/03/2004
14/01/2005 Centralised - Variation EMEA/V/C/32/IB/22
Updated with Decision(2005)3250 of 18/08/2005
19/04/2005 Centralised - Variation EMEA/V/C/32/IB/23
22/08/2005 Centralised - Variation (2005)3250 of 18/08/2005
15/11/2007 Centralised - Renewal EMEA/V/C/32/R/24 (2007)5553 of 13/11/2007
27/08/2008 Centralised - Variation EMEA/V/C/32/IA/27
Updated with Decision(2009)2305 of 25/03/2009
27/08/2008 Centralised - Variation EMEA/V/C/32/IA/25
Updated with Decision(2009)2305 of 25/03/2009
27/08/2008 Centralised - Variation EMEA/V/C/32/IA/26
Updated with Decision(2009)2305 of 25/03/2009
20/03/2009 Centralised - Variation EMEA/V/C/32/IB/28
27/03/2009 Centralised - Variation (2009)2305 of 25/03/2009
06/11/2009 Centralised - Variation EMEA/V/C/32/IB/29
22/12/2009 Centralised - Variation EMEA/V/C/32/IA/32
22/12/2009 Centralised - Variation EMEA/V/C/32/IA/33
22/12/2009 Centralised - Variation EMEA/V/C/32/IA/30
22/12/2009 Centralised - Variation EMEA/V/C/32/IA/31
02/02/2010 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/32/T/34 (2010)707 of 29/01/2010
16/04/2010 Centralised - Variation EMEA/V/C/32/IB/35/G
Updated with Decision(2010)7210 of 14/10/2010
18/10/2010 Centralised - Variation (2010)7210 of 14/10/2010
24/05/2013 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/32/T/36 (2013)3110 of 22/05/2013